CD22-TARGETED IMMUNOTHERAPY FOR ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-ALL WHO PREVIOUSLY EXPOSED TO CD19-TARGETED IMMUNOTHERAPY

被引:0
作者
Zhang, Mingming [1 ,2 ]
Hu, Yongxian [1 ,2 ]
Lu, Peihua [3 ,4 ]
Huang, Liang [5 ]
Fu, Shan [1 ,2 ]
Feng, Jingjing [1 ,2 ]
Hong, Ruimin [1 ,2 ]
Chang, Alex H. [6 ]
Huang, He [1 ,2 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
[2] Liangzhu Lab, Hangzhou, Peoples R China
[3] Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China
[4] Lu Daopei Inst Hematol, Beijing, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Peoples R China
[6] Shanghai YaKe Biotechnol, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P007
引用
收藏
页码:146 / 146
页数:1
相关论文
empty
未找到相关数据